1
Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant (HCT)
Condition(s):Acute GVHDLast Updated:February 22, 2023Recruiting
Tacrolimus: 1666 Clinical Trials, Page 1 of 167
Hide Studies Not Open or Pending
2
Tacrolimus Versus Hydrocortisone in Atopic Dermatitis
Condition(s):Atopic; DermatitisLast Updated:July 24, 2023Completed
3
Tacrolimus Treatment for Refractory Autoimmune Cytopenia
Condition(s):Autoimmune Hemolytic Anemia; Pure Red Cell Aplasia; Evans SyndromeLast Updated:December 3, 2019Unknown status
4
Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations
Condition(s):Liver Transplantation; Immunosuppression; Neurotoxicity; Tremor; TacrolimusLast Updated:October 22, 2021Not yet recruiting
5
Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus
Condition(s):Transplant;Failure,KidneyLast Updated:November 8, 2022Recruiting
6
OPTImization of the Dose of tacroliMUS by Bayesian Prediction
Condition(s):KIDNEY TRANSPLANTATIONLast Updated:January 8, 2021Completed
7
Precision Guided Tacrolimus Dosing in Pediatric Heart Transplant
Condition(s):Heart Transplant Failure and RejectionLast Updated:May 19, 2023Recruiting
8
Tacrolimus Treatment for Refractory PRCA
Condition(s):Pure Red Cell AplasiaLast Updated:May 30, 2018Unknown status
9
Study of the Cellular Diffusion of Tacrolimus Across the Membrane of Mononuclear Cells
Condition(s):HemochromatosisLast Updated:September 4, 2018Completed
10
A Pharmacokinetic Analysis of Tacrolimus ER Dosing in Obese Kidney Transplant Recipients
Condition(s):Kidney TransplantationLast Updated:November 7, 2018Completed